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cmbrosino  and  his  colleagues  from  an  Italian  center  at  Pisa,
escribe  their  experience  with  a  signiﬁcant  impact  on  the
anagement  of  home-ventilated  ALS  patients.  This  work
ertainly  opens  a  new  era  by  encouraging  new  studies  on
linical  evolution  and  prognosis,  thereby  deemed  to  reduce
he  uncertainties  experienced  for  all  of  those  responsible
or  the  follow-up  of  these  patients  that  may  improve  the
alliative  care  at  the  end-of-life.
Recent  evidence  aggregating  results  from  retrospective
nalysis  of  autopsies  of  ALS  patients  with  their  respective
eported  clinical  causes,  showed  that  despite  the  frequent
ack  of  concordance,  they  found  that  respiratory  infectious
onditions  were  the  most  prominent  features  and  that  pul-
onary  embolism  was  observed  only  in  spinal  ALS  patients,
nd  heart  failure  as  unexplained  death  was  more  than  two-
old  higher  in  bulbar  ALS  patients  than  in  the  spinal  forms.1
In  addition,  bulbar  ALS  patients  have  more  frequently  dis-
utonomy  and  sympathetic  hyperactivity,  and  speciﬁcally  in
entilated  ALS  patients  these  phenomena  have  already  been
or  many  years  described  and  recognized  as  possible  cause
f  unexpected  death  among  ventilated  patients.2
Moreover,  it  is  recognized  that  diffuse  alveolar  hemor-
hage  is  also  an  unspeciﬁc  feature,  both  for  ARDS  with
echanically  lung  injury  produced  with  higher  lung  volume,
nd  bronchopneumonia.  Indeed,  Prost  and  colleagues  found
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ttp://dx.doi.org/10.1016/j.rppneu.2013.06.003trong  and  powerful  associations  between  those  clinical  con-
itions  in  multivariate  analysis.3
However,  as  Diaz  and  colleagues,  reported  that  diffuse
lveolar  hemorrhage  is  the  clinical  feature  that  often  may
ot  be  apparent  or  its  presentation  can  be  mistaken  for  an
lternative  disease  process,  and  may  be  completely  unrec-
gnized  even  in  ICU.4
Accordingly,  we  secured  it  to  the  so  called  ‘‘irrelevant
ata’’  on  the  2  previous  admissions  to  the  emergency  room
n  the  last  four  months  described  in  the  text  by  Ambrosino
nd  colleagues,  to  draw  attention  and  focus  to  this  critical
ondition  in  the  emergency  room.
Indeed,  the  presence  of  an  obvious  critically  ill  ALS
atient  like  the  one  reported  on  this  clinical  case,  probably
ith  an  end-stage  disease,  the  diffuse  alveolar  hemor-
hage  was  very  likely  the  cause  of  death.  Nevertheless,  the
tiology  attributed  to  malfunction  of  the  device  without  dis-
ussion  of  other  clinical  conditions  seemed  rather  partial
specially  because  of  the  high  frequency  of  other  possible
egative  events  in  ALS  patients.
Still,  it  is  not  disputable  the  interest  of  the  present
ase  study  and  future  research  should  cover  these  perti-
ent  issues,  as  it  is  granted  that  other  causes  of  death  are
mplicated  in  the  terminal  ALS  stages,  even  if  properly  and
dequately  invasively  ventilated.
Overall,  though  mechanically  assisted  invasive  venti-
ation  (MAIV)  is  often  believed  to  be  a  life-prolonging
ntervention,  it  is  not  devoid  of  serious  life-threatening
omplications,  and  the  long-term  medical  course  of  ALS  with
AIV  has  never  been  tested  in  a  randomized  trial  with  NIV
gia.  Published  by  Elsevier  España,  S.L.  All  rights  reserved.
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that  frequently  goes  up  to  24/24  and  also  to  the  point  of
total  locked-in  syndrome,  meaning  that,  especially  due  to
the  paucity  of  studies,  we  may  no  longer  consider  MAIV  as
the  ultimate  strategy  to  improve  survival  but  rather  it  should
be  more  extensively  evaluated.
On  the  other  hand,  as  the  risk  management  and  safety
of  the  home  ventilator  dependent  patient  is  impossible  to
guarantee5 especially  care  has  to  be  undertaken  by  man-
ufacturers  when  implementing  software  designs  to  detect
and  anticipate  possible  faulty  mechanisms.  They  should  be
readily  accessible  by  physicians,  providers,  patients  and  car-
ers,  and  assist  immediate  responses.  However,  even  in  the
last  generation  of  ventilators  the  alarm  signs  are  not  easily
transmitted,  mostly  due  to  the  protection  of  data  laws  that
do  not  allow  a  good  communication  with  carers  and  patients
which,  once  fully  educated  and  familiarized  with  problems
and  solutions  should  be  thought  as  the  true  experts  and  team
members.
In  conclusion,  though  the  authors  could  have  reported
a  more  detailed  clinical  case  and  improved  the  discus-
sion,  this  report  is  very  interesting  and  quite  important
and  possibly  may  represent  a  turning  point,  calling
for  more  detailed  studies  on  durability,  reviews  and
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aintenance  of  devices  as  well  as  in  imposed  demands  both
n  manufacturers  and  providers  and  regulatory  mechanisms
egarding  patient  safety.
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